New Insights into the Cell Biology of Hematopoietic Progenitors by Studying Prominin-1 (CD133) by Bauer, Nicola et al.




 Cells Tissues Organs 2008;188:127–138 
 DOI: 10.1159/000112847 
 New Insights into the Cell Biology of 
Hematopoietic Progenitors by Studying 
Prominin-1 (CD133) 
 Nicola Bauer a    Ana-Violeta Fonseca a    Mareike Florek b    Daniel Freund a    
József Jászai a    Martin Bornhäuser b    Christine A. Fargeas a    Denis Corbeil a 
 a  Tissue Engineering Laboratories, Biotec, Technische Universität Dresden, and  b  Medical Clinic and Polyclinic I, 
University Hospital Carl Gustav Carus,  Dresden , Germany 
 Introduction 
 The cell biology of stem and progenitor cells is now an 
emerging field that will allow us to better understand and 
eventually control the essential cellular mechanisms un-
derlying the unique properties of these cells such as, for 
instance, their self-renewal capacity and their ability to 
differentiate into specialized mature cells. It appears that 
the cellular environment in the vicinity of these stem 
cells plays a crucial role in the maintenance of their stem 
cell properties. Thus, the migration and/or interaction of 
stem and progenitor cells with a particular cellular niche 
are of central importance for their cell biology. Neverthe-
less, the molecular and cellular bases of these events re-
main poorly understood, although they are certainly of 
potential therapeutic relevance. This lack of knowledge is 
mainly due to the fact that the stem and progenitor cells 
are rare and/or hidden in a large heterogeneous cell pop-
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 Abstract 
 Prominin-1 (alias CD133) has received considerable interest 
because of its expression by several stem and progenitor 
cells originating from various sources, including the neural 
and hematopoietic systems. As a cell surface marker, prom-
inin-1 is now used for somatic stem cell isolation. Its expres-
sion in cancer stem cells has broadened its clinical value, as 
it might be useful to outline new prospects for more effec-
tive cancer therapies by targeting tumor-initiating cells. Cell 
biological studies of this molecule have demonstrated that 
it is specifically concentrated in various membrane struc-
tures that protrude from the planar areas of the plasmalem-
ma. Prominin-1 binds to the plasma membrane cholesterol 
and is associated with a particular membrane microdomain 
in a cholesterol-dependent manner. Although its physiolog-
ical function is not yet determined, it is becoming clear that 
this cell surface protein, as a unique marker of both plasma 
membrane protrusions and membrane microdomains, 
might reveal new aspects of the cell biology of rare stem and 
cancer stem cells. The aim of this review is to outline the re-
cent discoveries regarding the dynamic reorganization of 
the plasma membrane of rare CD133+ hematopoietic pro-
genitor cells during cell migration and division. 
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CXCR 4 C-X-C chemokine receptor 4
HSPCs hematopoietic stem and progenitor cells
ICAM intercellular adhesion molecule
MSCs mesenchymal stromal cells
PSGL P-selectin glycoprotein ligand
SDF-1 stromal cell-derived factor-1
 Bauer /Fonseca /Florek /Freund /Jászai /
Bornhäuser /Fargeas /Corbeil 
Cells Tissues Organs 2008;188:127–138128
ulation. The discovery of new cell surface markers, which 
allow their prospective isolation and characterization, 
opens a new avenue to study the stem cell biology. In this 
review, we will focus on one of the most extensively stud-
ied markers named prominin-1 (alias CD133). We will 
put special emphasis on the stem and progenitor cells 
found in the hematopoietic system.
 Prominin-1 (CD133) 
 A Stem Cell Marker 
 Since its discovery 10 years ago, prominin-1 has re-
ceived considerable interest given its expression by sev-
eral somatic stem and progenitor cells originating from 
various sources, including the neural and hematopoietic 
systems, and in embryonic stem cell-derived progenitors 
[Weigmann et al., 1997; Yin et al., 1997; Kania et al., 2005; 
for review, see Fargeas et al., 2006]. Murine prominin-1 
was identified as a novel marker of neuroepithelial cells, 
primary progenitor cells of the mammalian central ner-
vous system [Weigmann et al., 1997], whereas its human 
counterpart constituted a new hematopoietic stem and 
progenitor cell (HSPC) marker (initially referred to as 
AC133 antigen) [Miraglia et al., 1997; Yin et al., 1997]. As 
a cell surface marker, prominin-1 is now used for somat-
ic stem cell isolation [Yin et al., 1997; Uchida et al., 2000; 
Richardson et al., 2004; Lee et al., 2005]. CD133+ stem 
and progenitor cells might become clinically important, 
particularly with regard to brain injury/disease and bone 
marrow transplantation (see below). Prominin-1 as such 
might open new perspectives of gene therapy in stem cell 
tissue engineering [Fargeas et al., 2006; Brenner et al., 
2007; Jászai et al., 2007a].
 It is important to note that, although various stem and 
progenitor cells express prominin-1, its expression is not 
limited to primitive cells. For instance, prominin-1 is de-
tected in several epithelia in adult mice and humans 
where it appears to be restricted to the apical (luminal) 
side [Weigmann et al., 1997; Florek et al., 2005; Lardon et 
al., 2007; Jászai et al., 2007b; for reviews concerning its 
expression pattern, see Corbeil et al., 2001; Fargeas et al., 
2006].
 Prominin-1 and Plasma Membrane Protrusions  
 Prominin-1 is a pentaspan membrane glycoprotein 
that exhibits a profound preference for membrane curva-
ture, which is illustrated by its concentration in various 
structures having in common that they protrude from 
the planar areas of the plasmalemma such as microvilli, 
cilia and at the leading edge of lamellipodia [Weigmann 
et al., 1997; Corbeil et al., 2000; for review, see Corbeil et 
al., 2001]. The concentration of prominin-1 in 2 distinct 
types of plasma membrane protrusions with different 
structural bases (actin for the microvillus and tubulin for 
the cilium) suggests that the mechanism underlying its 
remarkable subcellular localization is independent of a 
direct interaction with the actin or tubulin network, un-
less prominin-1 binds directly to both types of cytoskel-
etal elements [Dubreuil et al., 2007; Florek et al., 2007]. 
The latter scenario is highly unlikely, since the deletion 
of its C-terminal cytoplasmic tail (the only plausible cy-
toskeleton-interacting domain) does not prevent its con-
centration in plasma membrane protrusions [Corbeil et 
al., 1999].
 Several splice variants affecting the protein sequence 
of prominin-1 have been identified [Yu et al., 2002; Far-
geas et al., 2003, 2004, 2007]. Although they display a 
broad range of expression, all appear to be confined to 
plasma membrane protrusions. For instance, a specific 
prominin-1 variant named s3 [for nomenclature, see Far-
geas et al., 2007] is found in the myelin sheath [Corbeil et 
al., manuscript under revision], which represents a spe-
cialized plasma membrane protrusion of oligodendro-
cytes. Another variant, s6, is located in the tail of devel-
oping spermatozoa [Fargeas et al., 2004]. Prominin-1 is 
also concentrated in plasma membrane evaginations lo-
cated at the base of the outer segment of photoreceptor 
cells, which are the precursor structures in the biogenesis 
of photoreceptor disks [Maw et al., 2000]. This particular 
subcellular localization is interesting, given that muta-
tions in the human  PROMININ-1 gene are associated 
with a retinal degeneration suggesting that this mem-
brane protein might play a role in disk morphogenesis 
[Maw et al., 2000; Jászai et al., 2007a; Zhang et al., 
2007].
 Prominin-1 and Membrane Microdomains  
 Prominin-1 is a cholesterol-binding glycoprotein 
which is associated with a membrane microdomain (of-
ten referred to as ‘lipid microdomain’ or ‘lipid raft’) [for 
a unified definition, see Pike, 2006] containing the gan-
glioside GM1 in a cholesterol-dependent manner [Röper 
et al., 2000; Janich and Corbeil, 2007]. Membrane micro-
domains are viewed as liquid-ordered domains that are 
more tightly packed than the surrounding phase of the 
bilayer. They are enriched in sterol and sphingolipids 
present in the exoplasmic membrane leaflet and contain 
a specific set of membrane and peripheral proteins [Pike, 
2004]. Interestingly, the integrity of these membrane mi-
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crodomains appears essential to the maintenance of 
prominin-1 localization in plasma membrane protru-
sions as demonstrated by its dispersion upon cholesterol 
depletion [Röper et al., 2000].
 The association of prominin-1 with membrane micro-
domains, which are known to be implicated in several 
signaling cascades by allowing the formation of active 
transduction complexes [Simons and Toomre, 2000], is 
highly interesting particularly with regard to its expres-
sion in stem and progenitor cells. The prominin-1-con-
taining membrane microdomains might carry all molec-
ular determinants necessary to maintain the stem cell 
properties and their loss, for example via an asymmetric 
cell division, might contribute to cell differentiation (see 
below) [Kosodo et al., 2004; Fargeas et al., 2006].
 Prominosomes 
 Although tightly associated with the plasma mem-
brane via its 5 transmembrane segments, prominin-1 is 
nonetheless released into various physiological body flu-
ids including saliva, urine, seminal fluid and tears [Mar-
zesco et al., 2005; Florek et al., 2007]. In these fluids, 
prominin-1 is associated with small membrane vesicles 
(50–80 nm), referred to as prominosomes [Marzesco et 
al., 2005], which might arise, at least in part, from micro-
villi and/or primary cilia where prominin-1 appears con-
centrated at their tips [Weigmann et al., 1997; Dubreuil 
et al., 2007; Florek et al., 2007]. In the developing central 
nervous system of mammals, prominin-1 is not only as-
sociated with small membrane vesicles, but also with api-
cal midbodies that are released into the neural tube fluid 
[Dubreuil et al., 2007]. Their role is currently unknown. 
Nevertheless, we can hypothesize that the release of these 
various membrane particles by stem and progenitor cells, 
for example neuroepithelial [Marzesco et al., 2005; Du-
breuil et al., 2007] and hematopoietic progenitors [Bauer 
et al., manuscript in preparation], might be a means of 
disposal of a ‘stem cell-specific membrane microdomain’, 
allowing these cells to modify their stem and progenitor 
cell properties (see above). Alternatively, the prominin-1-
containing membrane particles might play a role in inter-
cellular communication by carrying specific signaling 
molecules. Such a scenario, without excluding the former 
one, would be particularly relevant in the context of tis-
sue formation.
 Although the physiological function of prominin-1 is 
not yet determined, it becomes clear that this cholesterol-
binding protein, as a unique marker of both plasma mem-
brane protrusions and membrane microdomains, might 
reveal new aspects of the cell biology of stem and pro-
genitor cells, particularly with regard to their plasma 
membrane organization during cell migration and divi-
sion.
 CD133+ HSPCs 
 Clinical Value 
 Hematopoiesis is maintained by a small number of 
HSPCs, which are able to proliferate and differentiate 
into all lineages of the hematopoietic system. Since these 
rare primitive cells reside within a large heterogeneous 
cell population, their proper isolation and in vivo charac-
terization inside the bone marrow compartment rely on 
the presence and/or absence of specific plasma mem-
brane markers. Throughout the last decade, monoclonal 
antibodies against the human sialomucin CD34 [Krause 
et al., 1996] have been used to isolate HSPCs. These cells 
were initially selected using immunoadsorptive methods 
and fluorescence-activated cell sorting, but soon the se-
lection of CD34+ HSPCs by paramagnetic bead-coupled 
antibodies became the method of choice in clinical stem 
cell transplantation [Beaujean, 1997]. 
 Prominin-1 is expressed on a subpopulation of CD34+ 
HSPCs derived from various sources including fetal liver 
and bone marrow, adult bone marrow, cord blood and 
mobilized peripheral blood [Miraglia et al., 1997; Yin et 
al., 1997; de Wynter et al., 1998; Corbeil et al., 2000]. The 
proportion of CD133+ cells within the CD34+ popula-
tion varies depending on the source of HSPCs (35–90%) 
with large discrepancies in the data reported by indepen-
dent research groups [Matsumoto et al., 2000]. Moreover, 
a unique population of CD34– HSPCs expressing prom-
inin-1 with primitive stem cell properties has been re-
ported [Gallacher et al., 2000; Kuci et al., 2003]. The 
CD133+ HSPCs have the capacity to reconstitute the en-
tire immune system of lethally irradiated mice [de Wyn-
ter et al., 1998]. Besides their hematopoietic capacity, 
these cells are capable of in vitro differentiation into neu-
ronal cells [Padovan et al., 2003], endothelial cells [Geh-
ling et al., 2000; Quirici et al., 2001] and myoblasts [Tor-
rente et al., 2004], suggesting broader multipotential ca-
pacities of CD133+ populations compared to the CD34+ 
ones.
 Interestingly, an immunomagnetic selection of 
CD133+ HSPCs allowed the enrichment of a sufficient 
amount of cells to perform hematopoietic stem cell trans-
plantation [Gordon et al., 2003], and pilot trials with leu-
kemic children have proven the feasibility of CD133+ se-
lection for allogeneic transplantation [Koehl et al., 2002; 
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Lang et al., 2004]. Similarly, we could demonstrate a rap-
id establishment of donor dendritic cell chimerism after 
allogeneic transplantation of CD133+ selected cells 
[Bornhäuser et al., 2005]. Other studies have shown the 
successful transplantation of haploidentically mis-
matched peripheral blood stem cells using CD133+ puri-
fied stem cells [Bitan et al., 2005]. Thus, the immunomag-
netic isolation procedure of HSPCs based on prominin-1 
appears to be an interesting alternative to CD34 [Freund 
et al., 2006a]. 
 Prominin-1, in addition to being normally expressed 
on the surface of HSPCs, is detected in various malignant 
hematopoietic diseases including acute and chronic my-
eloid as well as lymphoblastic leukemias [for review, see 
Bhatia, 2001]. In most leukemias, both prominin-1 and 
CD34 are expressed, but some investigators have identi-
fied leukemic blasts harboring prominin-1 but not CD34 
[Kratz-Albers et al., 1998]. The dual expression of prom-
inin-1 by HSPCs and by their leukemic counterparts is 
highly consistent with the cancer stem cell hypothesis, 
which suggests that not all cells in a tumor have the same 
capacity to proliferate [Bonnet and Dick, 1997]. In fact, 
the CD133+ cells might represent a unique population of 
cancer stem cells that possess the ability to proliferate and 
maintain their self-renewal capacity extensively in an un-
controlled fashion. A similar conclusion has been drawn 
recently based on the expression of prominin-1 in solid 
cancer cells that are capable of initiating tumor growth 
[Singh et al., 2004; O’Brien et al., 2007; Ricci-Vitiani et al., 
2007]. Thus, prominin-1 might be useful to outline new 
prospects for more effective cancer therapies by targeting 
tumor-initiating cells. 
 Cell Shape and Migration  
 The trafficking of HSPCs is a fundamental process not 
only during ontogenesis where the primitive HSPCs move 
by sequential events from the yolk sac and/or aorta-go-
nad-mesonephros to the fetal liver/spleen and finally to 
the adult bone marrow, but also during steady-state ho-
meostasis – a phenomenon occurring throughout the en-
tire adult life. In many aspects, the homing of infused 
HSPCs to the adult bone marrow microenvironment and 
their mobilization from this specialized endosteal/endo-
thelial niche [for reviews, see Adams and Scadden, 2006; 
Kiel and Morrison, 2006; Li and Li, 2006; Wilson and 
Trumpp, 2006] to the peripheral blood, following admin-
istration of chemotherapeutic agents, mimic the physio-
logical migration of HSPCs during embryogenesis. The 
orchestrated processes underlying the HSPC trafficking 
require a high degree of molecular specificity [Hardy, 
1995; Papayannopoulou et al., 1995; Cancelas et al., 2006] 
and possibly plasma membrane flexibility. Despite the 
central role of these events in hematopoietic stem cell bi-
ology and their therapeutic relevance, their molecular 
and cellular bases still remain poorly understood [Wright 
et al., 2001].
 It is likely that the HSPC trafficking to some extent 
mimics the multistep migration process of peripheral 
leukocytes to inflammatory sites [Butcher and Picker, 
1996; Luster et al., 2005]. An important prerequisite for 
such migration is the acquisition of a polarized morphol-
ogy through reorganization of the cytoskeleton elements 
that is conducted, at least in part, by the activation of 
small Rho GTPase proteins [for review, see Sanchez-Ma-
drid and del Pozo, 1999] and results in the formation of a 
lamellipodium-like structure at the front side (leading 
edge) and a uropod at the rear pole. The uropod is a spe-
cialized pseudopod-like projection with important func-
tions including motility and recruitment of bystander 
cells.
 Using a coculture consisting of human CD133/34+ 
HSPCs growing on a monolayer of human primary mul-
tipotent mesenchymal stromal cells (MSCs) in the pres-
ence of relevant cytokines [for technical details, see 
Freund et al., 2006b], we and others have shown that mi-
grating HSPCs exhibit a leukocyte-like polarized mor-
phology ( fig. 1 a) [Fruehauf et al., 2002; Giebel et al., 2004; 
Freund et al., 2006b; Wagner et al., 2007]. Interesting-
ly, several membrane proteins are selectively segre-
gated upon polarization. For instance, prominin-1 is se-
lectively concentrated in the uropod ( fig. 1 b), whereas
the G protein-coupled 7-span transmembrane receptor 
CXCR4 – a chemokine stromal cell-derived factor 1
(SDF-1) receptor – is found at the leading edge [Giebel et 
al., 2004] in agreement with its role in directional cell mi-
gration through an SDF-1 gradient [for reviews, see La-
pidot and Kollet, 2002; Dar et al., 2006]. Numerous adhe-
sion molecules, including CD43, CD44, intercellular ad-
hesion molecule-1/3 and P-selectin glycoprotein ligand-1, 
are enriched in the uropod as shown for prominin-1 
( fig. 1 b, inset). Other molecules such as CD34 and CD45 
are randomly distributed [Giebel et al., 2004; Fonseca and 
Corbeil, unpubl. data].
 Given that the selective enrichment of prominin-1 in 
plasma membrane protrusions depends on a particular 
cholesterol-based membrane microdomain [Röper et al., 
2000], this observation points out that the lipid composi-
tion of the uropod might be distinct. Indeed, 2 raft-asso-
ciated gangliosides, GM 1 (as revealed by the binding of 
the cholera toxin B subunit) and GM 3 , are segregated in 
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 Fig. 1. HSPCs exhibit 2 distinct modes of locomotion.  a ,  e CD34+ 
MACS-immunoisolated HSPCs from leukapheresis products 
were cultured for 7 days on primary human MSCs prior to analy-
sis by scanning electron microscopy.  a–d The first type of loco-
motion involves the formation of a uropod at the rear pole and a 
leading edge at the front pole ( a ; solid lines). Both types of plasma 
membrane protrusions contain a specific membrane microdo-
main – the uropod is enriched in GM 1 ganglioside, whereas the 
leading edge is enriched in GM 3 ganglioside ( b ; red and green, 
respectively). In addition to prominin-1 (CD133), several cell ad-
hesion molecules are concentrated in GM 1 -based microdomain 
( b ; red box). CXCR4 is found at the leading edge and others such 
as CD34 and CD45 are distributed in a nonpolarized fashion ( b ). 
This mode of locomotion – where the uropod at the rear pole is 
up – is similar to that used by migrating leukocytes ( c ; arrow in-
dicates the direction of migration). When the uropod at the rear 
pole gets in contact with the MSC, the HSPCs stop their migration 
and start to rotate around the axis generated by the contact point 
( d ; curved arrow). The blue box highlights the contact zone be-
tween HSPC and MSC, which might be important for cellular 
communication.  e–h The second type of locomotion involves the 
formation of a large magnupodium emerging from an HSPC ( e , 
 f ; asterisks) that will grow and move underneath an MSC ( g ; ar-
row). When the magnupodium senses the appropriate niche, the 
entire cell body of the HSPC will move therein ( h ; arrow). Please 
note that during these movements the HSPC does not exhibit any 
uropod structure, which stands in contrast to those with a highly 
motile locomotion ( a–d ). The presence of prominin-1 at the edge 
of the magnupodium suggests that a specific membrane micro-
domain (red) might endow this plasma membrane subdomain 
with appropriate receptor/adhesion molecules such as CXCR4 ( f ). 
SDF-1 (green dots) secreted by MSCs might attract and guide the 
magnupodium via its receptor CXCR4 ( f ). The original picture in 
 e was previously presented in Freund et al. [2006b]. ICAM = In-
tercellular adhesion molecule; PSGL = P-selectin glycoprotein li-
gand; SDF = stromal cell-derived factor. Scale bars = 10   m. 
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migrating HSPCs ( fig. 1 b) – GM 1 is enriched in the uro-
pod [Gillette et al., 2006], whereas GM 3 is found in the 
leading edge ( fig. 1 b) [Giebel et al., 2004]. A similar ob-
servation has previously been made with migrating leu-
kocytes, thus reinforcing the parallel in the polarization 
process between these 2 cell types [Gómez-Moutón et al., 
2001]. The concentration of prominin-1 in GM 1 -rich, but 
not GM 3 -rich membrane microdomains appears to be a 
general phenomenon, since a similar event occurs in po-
larized epithelial cells [Janich and Corbeil, 2007]. There-
fore, the polarization of migrating HSPCs might be driv-
en not only by cytoskeleton remodeling directed, for in-
stance, by small Rho GTPase [Giebel et al., 2004; 
Konakahara et al., 2004; Cancelas et al., 2006; Ghiaur et 
al., 2006; Yang et al., 2007], but also by a reorganization 
of their plasma membrane in terms of lipid microdo-
mains. The latter might be required to concentrate and/or 
retain a particular set of membrane proteins in a given 
subdomain, such as uropod or leading edge. It is interest-
ing to note that several adhesion membrane proteins are 
found in the uropod ( fig. 1 b) and, as a consequence, when 
this trailing edge protrusion touches the feeder cells, the 
HSPCs stop their migration ( fig. 1 c) and start to rotate 
around the axis generated by the contact point ( fig. 1 d) 
[Wagner et al., 2005; Fonseca and Corbeil, unpubl. 
data]. 
 We have recently demonstrated that CD133+ HSPCs 
adopt various other morphologies than the leukocyte-
like migrating structure. They develop several types of 
plasma membrane protrusions, including microvillus, 
magnupodium and lamellipodium, where prominin-1 is 
selectively concentrated [Corbeil et al., 2000; Freund et 
al., 2006b]. Although little is known about the physiolog-
ical role of these protrusions, they are generally consid-
ered to be involved in the homing of HSPCs into the bone 
marrow [Frimberger et al., 2001]. For instance, the large 
magnupodium moving underneath MSCs might act as a 
searching-sensor process to guide HSPCs to an appropri-
ate microenvironment ( fig. 1 e–h) [Konakahara et al., 
2004; Wagner et al., 2005; Freund et al., 2006b]. The ob-
servation that similar plasma membrane protrusions 
(named proteopodia), which are themselves highly mo-
tile even when the cells are not in rapid motion, were in-
duced by the chemotactic factor SDF-1 is in agreement 
with such a function [Frimberger et al., 2001]. It seems 
highly unlikely that the concentration of the CXCR4 re-
ceptor at the edge of the magnupodium [Freund et al., 
2006b] and the secretion of SDF-1 by MSCs would be un-
related events ( fig. 1 f) [Freund et al., 2006b; van Over-
straeten-Schlogel et al., 2006]. The concentration of 
prominin-1, contrary to CD34, at the edge of the magnu-
podium suggests that a specific membrane microdomain 
might indirectly trigger the formation of such a search-
ing-sensor process by clustering CXCR4 and other ap-
propriate adhesion molecules, such as CD54 and CD29 
[Konakahara et al., 2004; Freund et al., 2006b]. The cy-
toplasmic machinery, notably the Rho GTPase/LIM ki-
nase 1/cofilin pathway through CD29, might also be in-
volved in their biogenesis, as previously suggested [Ko-
nakahara et al., 2004]. It remains to be determined if a 
particular ganglioside is found therein, but it seems that 
an active remodeling of the plasma membrane is re-
quired.
 Thus HSPCs display 2 distinct modes of locomotion, 
which result in important morphological changes ( fig. 1 ). 
The first mimics the migration of highly motile leuko-
cytes with the formation of a uropod subdomain at the 
rear pole ( fig. 1 a–d). This type of locomotion might play 
a role in the trafficking of HSPCs inside the blood vessel 
and during the transendothelial migration. The second 
involves the generation of a searching-sensor magnupo-
dium at the front side that might guide HSPCs to the final 
destination inside the bone marrow medullary cavity 
( fig. 1 e–h). Further studies involving, for instance, an in-
travital microscopy model are needed to establish the 
physiological relevance of these migration behaviors. 
Our increasing knowledge concerning the migration 
mechanisms of HSPCs should help to improve the pro-
cess of homing and engraftment of infused cells in med-
ical application. 
 Intercellular Communication 
 An important aspect of the cellular biology of HSPCs 
is to understand how these cells can communicate with 
their cellular microenvironment known as the stem cell 
niche. Various mechanisms for the exchange of molecu-
lar information between cells have been documented. 
The secretion of molecules and their interaction with 
their receptors located on the target cells or contact-de-
pendent signaling are good examples. The SDF-1 and 
CXCR4 signaling axis falls into the first category [Faber 
et al., 2007], whereas the Notch/Delta signaling falls into 
the second [Varnum-Finney et al., 2000]. Gerdes et al. 
[2007] have proposed a third way for mammalian cells to 
communicate based on the formation of thin membrane 
channels between them. Remarkably, we could observe 
that HSPCs develop peculiar thin plasma membrane 
structures (diameter 50–80 nm), which link 2 or more 
adjacent HSPCs, leading to the formation of complex cel-
lular networks [Freund et al., 2006b]. These structures 
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are highly reminiscent of the tunneling nanotubes that 
allow the direct intercellular transfer of diverse compo-
nents (molecules, small and large organelles such as mi-
tochondria) and might act, in contrast to gap junctions, 
at a long range [Rustom et al., 2004]. It remains to be es-
tablished which information HSPCs might share, but it is 
tempting to speculate that such membrane processes 
might allow them to sense the presence or absence of 
their neighbors within the niche. As a consequence, 2 sce-
narios are possible: first, a signal might be transduced 
within the connected cells, which will lead to a steady 
state, that is, nonproliferation. Second, the absence of in-
teraction might result in proliferation, permitting the re-
plenishment of the niche.
 Lippincott-Schwartz and colleagues have recently pro-
posed an alternative way for the HSPCs to communicate 
with their cellular environment, which involves the con-
tact zone between the HSPCs’ uropod and the feeder cells 
( fig. 1 d, blue box) [Gillette et al., 2006]. This cell-cell con-
tact zone might serve as an intimate room for intercellu-
lar communication where HSPCs’ plasma membrane 
proteins including prominin-1 are transferred to the 
feeder cells [Gillette et al., 2006]. Although such an event 
would have an important implication for the interaction/
communication of HSPCs with their cellular niche, the 
cellular mechanism underlying this transfer of molecules 
is currently unknown. However, knowing that prominin-
1 is associated with small membrane vesicles that are re-
leased not only from the neuroepithelial cells (see above), 
but also from HSPCs [Bauer et al., manuscript in prepa-
ration], it is tempting to speculate that these vesicles are 
the carrier involved in such molecule shuttling. It cannot 
be a coincidence that prominin-1 is concentrated in the 
uropod and that this particular plasma membrane sub-
domain is implicated in the budding of human immuno-
deficiency virus type 1 particles produced by infected T 
cell lines [Nguyen and Hildreth, 2000]. However, we can-
not exclude other sources for these particles, since prom-
inin-1 also appears to be associated with multivesicular 
bodies in HSPCs [Bauer et al., 2007, manuscript in prepa-
ration] and it might be released into the extracellular en-
vironment associated with exosomes [Février and Rapo-
so, 2004].
 Clearly, the cellular communication of HSPCs is a 
novel research field that requires further investigation, 
and the development of ex vivo cultures [Dexter et al., 
1977; Majumdar et al., 2000; Kadereit et al., 2002; Wagner 
et al., 2005; Freund et al., 2006b], mimicking the bone 
marrow niche, might help to address this issue.
 Cellular Polarization and Cell Division 
 Little is known about the plasma membrane polarity 
of HSPCs and the distribution of membrane components 
during cell division. The identification of intrinsic factors 
playing a role in the maintenance of their stem cell prop-
erties is highly important. The symmetric versus asym-
metric distribution of such determinants during cell di-
vision might govern the fate of the daughter cells. Conse-
quently, new cell-based therapeutic strategies might 
eventually arise from the manipulation of these determi-
nants. The expression of prominin-1 in stem cells origi-
nating from various tissues suggests that it might be im-
plicated in the determination of cell fate, although this 
remains to be elucidated [Kosodo et al., 2004]. Neverthe-
less, its dual association with plasma membrane protru-
sions and membrane microdomains deserves particular 
consideration. In the same way, the subcellular localiza-
tion of prominin-1 might also be instructive with regard 
to the general organization of the plasma membrane of 
nonmigrating HSPCs. Thus, we have demonstrated that 
small microvillar-like structures, where prominin-1 is 
selectively concentrated [Corbeil et al., 2000], were ran-
domly distributed over the entire surface of HSPCs either 
derived from peripheral blood immediately upon granu-
locyte colony-stimulating factor mobilization ( fig. 2 a) 
[Freund et al., 2006b] or freshly isolated from umbilical 
cord blood [Giebel et al., 2004]. A comparable distribu-
tion was observed for CD34 ( fig. 2 b), although this mark-
er was not selectively associated with plasma membrane 
protrusions [Corbeil et al., 2000]. Interestingly, a similar 
analysis of hematopoietic cells derived from leukemic 
blasts revealed that, while CD34 was randomly distrib-
uted over the entire cell surface ( fig. 2 d), prominin-1 was 
concentrated on one side or pole, leading to the polariza-
tion of the plasma membrane of these cells ( fig. 2 c, solid 
line). Remarkably, the polarization of HSPCs also oc-
curred upon contact with the feeder cell layer leading to 
the formation of a microvillar pole evidenced by the clus-
tering of prominin-1 ( fig. 2 e), which could also be visual-
ized by scanning electron microscopy ( fig. 2 f) [Freund et 
al., 2006b]. The physiological relevance of the microvillar 
pole is currently unknown, but the polarization of prom-
inin-1 clearly reflects the plasma membrane compart-
mentalization of HSPCs. Such a phenomenon might be 
related to the quiescence or proliferation of HSPCs. In 
this particular context it is highly interesting to note that 
the hematopoietic cells including the CD133+ cell popu-
lation are in G 0 /G 1 phase immediately upon immunoiso-
lation from umbilical cord blood [Grskovic et al., 2004], 
suggesting that the absence of a microvillar pole might be 
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correlated to a quiescent state of the cells. Vice versa, 
HSPC polarization might be related to proliferation, 
which was exactly the case when the HSPCs were cul-
tured ex vivo [Freund et al., 2006b]. The same holds true 
for their leukemic counterparts. Thus, polarization of 
HSPCs might be an indicator of their proliferative status. 
Further studies involving time lapse video microscopy 
are needed to dissect this issue.
 A detailed analysis of various phases of mitotic HSPCs, 
derived from leukapheresis products, growing on MSCs 
as a feeder cell layer, revealed a complex distribution of 
prominin-1 (for details, see fig. 3 in Fargeas et al. [2006]). 
For instance, prominin-1, but not CD34, becomes con-
centrated in surface domains corresponding to the spin-
dle pole region during metaphase. In early and late ana-
phase, prominin-1 is enriched towards the cleavage fur-
row, and in some cases, also remained clustered at 1 pole 
of the dividing cells [Fargeas et al., 2006; Beckmann et al., 
2007]. This concentration of prominin-1 in the cleavage 
furrow is consistent with the enrichment of microvillar-
like structures therein, as observed in the RBL-2H3 cell 
line [Yonemura et al., 1993]. In telophase and cytokinesis, 
prominin-1 is either equally or unequally distributed be-
tween the 2 nascent daughter cells ( fig. 3 , left) [Fargeas et 
al., 2006]. A similar symmetric or asymmetric distribu-
tion of prominin-1 was observed when the HSPCs were 
Prominin-1Prominin-1







 Fig. 2. Polarization of HSPCs and their leukemic counterparts as 
revealed by the subcellular localization of prominin-1. Human 
hematopoietic cells from leukapheresis products ( a ,  b ) and from 
an acute myeloid leukemia ( c ,  d ; subtype M2 according to French-
American-British classification) were fixed with 4% paraformal-
dehyde at room temperature prior to labeling with either mouse 
monoclonal antibody CD133/1 (anti-prominin-1; Miltenyi Bio-
tec) or mouse monoclonal antibody CD34 (clone 581; BD Pharmin-
gen) followed by Cy3-conjugated goat anti-mouse IgG (Jackson 
Immunoresearch). Nuclei were visualized with 4,6-diamidino-2-
phenylindrole. The immunofluorescence analysis was performed 
using a confocal microscope.  a–d A composite x-y picture from 8 
optical sections is shown.  e ,  f In the coculture experiment, CD34+ 
MACS-immunoisolated cells (HSPCs) from leukapheresis prod-
ucts were cultured for 7 days on primary human MSCs prior to 
the labeling procedure as described previously [Freund et al., 
2006b].  e A single z section is shown. Solid lines indicate the po-
larization of prominin-1; the dashed line shows the level of MSC. 
 f Scanning electron microscopy analysis of HSPCs growing on 
MSCs reveals the presence of a microvillar pole (dotted line) on 
HSPCs exhibiting a round morphology. Scale bars = 5   m. 
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cultured either on fibronectin-coated or uncoated glass 
coverslips, indicating that such a phenomenon is inde-
pendent of extrinsic factors ( fig. 3 , right; data not shown). 
These observations are not unique to the hematopoietic 
cells, since a similar phenomenon, that is, symmetric ver-
sus asymmetric distribution of prominin-1, has already 
been described in mammalian neu roepithelial progeni-
tors [Kosodo et al., 2004]. During neurogenesis, prom-
inin-1 is also highly concentrated in midbodies of sym-
metrically dividing neuroepithelial progenitors [Du-
breuil et al., 2007], in contrast to HSPCs ( fig. 3 , arrows) 
[Fargeas et al., 2006]. However, some investigators have 
recently observed a certain amount of prominin-1 in 
midbodies of dividing HSPCs derived from umbilical 
cord blood [Beckmann et al., 2007]. Future studies are 
necessary to determine the cell biological consequences 
of such an asymmetric distribution of prominin-1, but 
knowing that this cholesterol-binding protein is associ-
ated with a specific membrane microdomain (see above), 
one might consider that its unequal distribution reflects 
the asymmetric distribution of these microdomains. The 
concept of stem cell-specific membrane microdomains 
carrying all molecular determinants necessary to main-
tain the stem cell properties is highly appealing in this 
context. Alternatively, these stem cell membrane micro-
domains might also be eliminated from the plasma mem-
brane either by selective release from microvillar-like 
structures as membrane vesicles, such as the promino-
somes described above [Marzesco et al., 2005; Bauer et al., 
2007, manuscript in preparation], or, in HSPCs, by endo-
cytosis into the multivesicular bodies and eventual re-
lease with exosomes [Bauer et al., 2007]. Both mecha-
nisms are not mutually exclusive, although the associa-
tion of prominin-1 with multivesicular bodies has not 
been reported in neuroepithelial cells [Marzesco et al., 




HSPCs growing on MSCs HSPCs growing on fibronectin
HSPCs growing on glass
DAPI
  Fig. 3. Symmetric and asymmetric cell
division of HSPCs growing on various
surfaces. CD34+ MACS-immunoisolated 
cells (HSPCs) from leukapheresis products 
were cultured for 3 days on either primary 
human MSCs, or fibronectin-coated or 
uncoated glass coverslips prior to the la-
beling procedure [Fargeas et al., 2006]. 
Paraformaldehyde-fixed, saponin-perme-
abilized cells were labeled with mouse 
monoclonal antibody CD133/1 (anti-
prominin-1; Miltenyi Biotec; red) and rat 
monoclonal antibody anti-  -tubulin (Se-
rotec; green) followed by appropriate Cy3- 
and Cy2-conjugated secondary antibodies 
before double immuno fluorescence analy-
sis using confocal microscopy. Nuclei were 
visualized with 4,6-diamidino-2-phenyl-
indrole. A composite of 9 optical sections 
is shown. White arrows indicate the mid-
body. Scale bars = 5   m. 
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 Conclusions 
 In conclusion, prominin-1, as a stem and progenitor 
marker, has rapidly become a tool generally used to de-
fine a self-renewing cell population in various tissues, 
which is highly important for tissue engineering and 
stem cell-based therapies. Its association with potential 
cancer stem cells might contribute to outline new pros-
pects for more effective cancer therapy by targeting tu-
mor-initiating cells. As a marker of plasma membrane 
protrusions and membrane microdomains, prominin-1 
has already highlighted novel cell biological aspects, par-
ticularly regarding the general organization of the plasma 
membrane of stem and progenitor cells. In the future, the 
prominin-1-containing membrane microdomain associ-
ated with these primitive cells and the prominosomes re-
leased by them should reveal the peculiar mechanisms 
underlying stem cell properties.
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